Interleukin-6 as a therapeutic target in diabetic macular edema: current evidence and future perspectives
{{output}}
Introduction: Diabetic macular edema (DME) is a major cause of vision loss in diabetic retinopathy. Although anti-vascular endothelial growth factor (VEGF) therapy is the current standard treatment, many patients show incomplete ... ...
